Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Bladder Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    June 2008
  1. DREICER R , Li H, Cooney MM, Wilding G, et al
    Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology Group.
    Cancer. 2008;112:2671-5.
    PubMed     Related articles    Abstract available


  2. DECOBERT M , Larue H, Harel F, Meyer F, et al
    Maintenance bacillus Calmette-Guerin in high-risk nonmuscle-invasive bladder cancer: how much is enough?
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


  3. KAMAT AM
    Intravesical BCG for bladder cancer: how much is enough?
    Cancer. 2008;.
    PubMed     Related articles   


    May 2008
  4. HIGANO CS , Tangen CM, Sakr WA, Faulkner J, et al
    Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
    Cancer. 2008;112:2181-7.
    PubMed     Related articles    Abstract available


    April 2008
  5. KOPPIE TM , Serio AM, Vickers AJ, Vora K, et al
    Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    March 2008
  6. YE Y , Yang H, Grossman HB, Dinney C, et al
    Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  7. HOLLENBECK BK , Ye Z, Wong SL, Montie JE, et al
    Hospital lymph node counts and survival after radical cystectomy.
    Cancer. 2008;112:806-12.
    PubMed     Related articles    Abstract available


  8. BARBISAN F , Santinelli A, Mazzucchelli R, Lopez-Beltran A, et al
    Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
    Cancer. 2008;112:636-44.
    PubMed     Related articles    Abstract available


    December 2007
  9. MOLINA JR , Quevedo JF, Furth AF, Richardson RL, et al
    Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
    Cancer. 2007;110:2434-40.
    PubMed     Related articles    Abstract available


    November 2007
  10. PERDONA S , Autorino R, Damiano R, De Sio M, et al
    Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer : a multi-institutional, long-term experience.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  11. SHARIAT SF , Karakiewicz PI, Ashfaq R, Lerner SP, et al
    Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    October 2007
  12. DANIELY M , Rona R, Kaplan T, Olsfanger S, et al
    Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  13. CARAWAY NP , Khanna A, Payne L, Kamat AM, et al
    Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
    Cancer. 2007;111:323-9.
    PubMed     Related articles    Abstract available


  14. NOVARA G , De Marco V, Gottardo F, Dalpiaz O, et al
    Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Cancer. 2007;110:1715-22.
    PubMed     Related articles    Abstract available


  15. CLARK PE
    Upper tract transitional cell carcinoma: finding a way forward.
    Cancer. 2007;110:1648-9.
    PubMed     Related articles   


    August 2007
  16. KASSOUF W , Spiess PE, Siefker-Radtke A, Swanson D, et al
    Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
    Cancer. 2007;110:764-9.
    PubMed     Related articles    Abstract available


  17. DREICER R , Li S, Manola J, Haas NB, et al
    Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology Group.
    Cancer. 2007;110:759-63.
    PubMed     Related articles    Abstract available


    May 2007
  18. KAMAT AM , Dinney CP, Gee JR, Grossman HB, et al
    Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


    April 2007
  19. INMAN BA , Sebo TJ, Frigola X, Dong H, et al
    PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
    Cancer. 2007;109:1499-505.
    PubMed     Related articles    Abstract available


  20. CHANG CH , Yang CM, Yang AH
    Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan.
    Cancer. 2007;109:1487-92.
    PubMed     Related articles    Abstract available


    March 2007
  21. KRAMER C , Klasmeyer K, Bojar H, Schulz WA, et al
    Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  22. GILBERT SM , Wood DP, Dunn RL, Weizer AZ, et al
    Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  23. CAI T , Bartoletti R
    Long-term outcome of hematuria home screening for bladder cancer in men.
    Cancer. 2007;.
    PubMed     Related articles   


    February 2007
  24. SHARIAT SF , Ashfaq R, Karakiewicz PI, Saeedi O, et al
    Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  25. ESUVARANATHAN K , Chiong E, Thamboo TP, Chan YH, et al
    Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.
    Cancer. 2007;.
    PubMed     Related articles    Abstract available


  26. GALSKY MD , Iasonos A, Mironov S, Scattergood J, et al
    Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.
    Cancer. 2007;109:549-55.
    PubMed     Related articles    Abstract available


  27. KONETY BR , Allareddy V, Carroll PR
    Factors affecting outcomes after radical cystectomy in African Americans.
    Cancer. 2007;109:542-8.
    PubMed     Related articles    Abstract available


    November 2006
  28. KOPPIE TM , Vickers AJ, Vora K, Dalbagni G, et al
    Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?
    Cancer. 2006;107:2368-74.
    PubMed     Related articles    Abstract available


    October 2006
  29. MESSING EM , Madeb R, Young T, Gilchrist KW, et al
    Long-term outcome of hematuria home screening for bladder cancer in men.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  30. GORE JL , Saigal CS, Hanley JM, Schonlau M, et al
    Variations in reconstruction after radical cystectomy.
    Cancer. 2006;107:729-37.
    PubMed     Related articles    Abstract available


  31. WRIGHT JL , Porter MP, Li CI, Lange PH, et al
    Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Cancer. 2006;107:721-8.
    PubMed     Related articles    Abstract available


  32. KASSOUF W , Leibovici D, Luongo T, Munsell MF, et al
    Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  33. DASH A , Galsky MD, Vickers AJ, Serio AM, et al
    Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.
    Cancer. 2006;107:506-13.
    PubMed     Related articles    Abstract available


    July 2006
  34. LOTAN Y , Svatek RS, Sagalowsky AI
    Should we screen for bladder cancer in a high-risk population?: a cost per life-year saved analysis.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  35. LIN J , Spitz MR, Dinney CP, Etzel CJ, et al
    Bladder cancer risk as modified by family history and smoking.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  36. COPP HL , Chin JL, Conaway M, Theodorescu D, et al
    Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
    Cancer. 2006;107:60-6.
    PubMed     Related articles    Abstract available


    May 2006
  37. SHEN SS , Smith CL, Hsieh JT, Yu J, et al
    Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  38. ALLAREDDY V , Kennedy J, West MM, Konety BR, et al
    Quality of life in long-term survivors of bladder cancer.
    Cancer. 2006;.
    PubMed     Related articles    Abstract available


  39. HOLLENBECK BK , Miller DC, Taub D, Dunn RL, et al
    Risk factors for adverse outcomes after transurethral resection of bladder tumors.
    Cancer. 2006;106:1527-35.
    PubMed     Related articles    Abstract available


    March 2006
  40. LIN CC , Hsu CH, Huang CY, Cheng AL, et al
    Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.
    Cancer. 2006;106:1269-75.
    PubMed     Related articles    Abstract available


  41. MHAWECH-FAUCEGLIA P , Cheney RT, Schwaller J
    Genetic alterations in urothelial bladder carcinoma: an updated review.
    Cancer. 2006;106:1205-16.
    PubMed     Related articles    Abstract available


    February 2006
  42. MIAN C , Maier K, Comploj E, Lodde M, et al
    uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses.
    Cancer. 2006;108:60-5.
    PubMed     Related articles    Abstract available


  43. RUGGERI EM , Giannarelli D, Bria E, Carlini P, et al
    Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies.
    Cancer. 2006;106:783-8.
    PubMed     Related articles    Abstract available


    January 2006
  44. BAMIAS A , Moulopoulos LA, Koutras A, Aravantinos G, et al
    The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
    Cancer. 2006;106:297-303.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: